Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase 2/3 1

Status

Completed 3Unknown 1

Sponsor Class

OTHER 221NIH 62NETWORK 51INDUSTRY 24OTHER_GOV 4

Study Type

Interventional 4Observational 1

Sponsor

Cancer Type

Lymphoid 2Sarcoma 1

Conditions

Lymphoma, Non-Hodgkin 2Lymphoma 2Osteosarcoma 1Neoplasms, Germ Cell and Embryonal 1Hodgkin Disease 1

Interventions

Cisplatin 48Capecitabine 41Gemcitabine 33apatinib 32Oxaliplatin 32Cyclophosphamide 31Radiotherapy 29Paclitaxel 29Carboplatin 29tislelizumab 27Irinotecan 27Drug Therapy 27Fluorouracil 26Docetaxel 26Bevacizumab 23fludarabine 18Nivolumab 17pembrolizumab 16Surgical Procedures, Operative 16Exercise 16Metformin 15S 1 (combination) 14camrelizumab 13Radiation 13Pemetrexed 13Control Groups 12anlotinib 11Leucovorin 11Vinorelbine 10Standard of Care 10

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
OTHER_GOV × Interventional × Ifosfamide × Clear all
NCT02414685 2020-08-07

TIP

National Cancer Institute, Slovakia

Phase 2 Completed
19 enrolled

Neoplasms, Germ Cell and Embryonal

NCT00280878 2016-01-15

Rituximab in Combination With Outpatient Therapy for CD20+ Lymphoma

Bayside Health

Phase 2 Completed
12 enrolled
Lymphoid

Lymphoma, Lymphoma, Non-Hodgkin

NCT00163761 2016-01-08

Efficacy Study of Outpatient Therapy for Lymphoma

Bayside Health

Phase 2 Completed
90 enrolled
Lymphoid

Hodgkin Disease, Lymphoma, Lymphoma, Non-Hodgkin

NCT00691236 2011-06-23

ZOL

Tata Memorial Hospital

Phase 2/3 Unknown
60 enrolled
Sarcoma

Osteosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡